|
|
|
| Effects of protein powder on the bioavailability of perfluoroalkyl substances in rat kidney |
| CAI Delei, ZHENG Yibin, XIA Yong, ZHANG Shixin, SONG Yanhua, SHEN Haitao, YAO Jin, CHEN Qing
|
| Department of Physicochemical and Toxicology, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China |
|
|
|
|
Abstract Objective To explore the effects of protein powder on the bioavailability of perfluoroalkyl substances (PFASs) in blood and kidneys of rats and renal function change. Methods Twenty-four rats of the SD strain were randomly divided into the negative control group, PFASs group and protein powder group, with 8 rats (half males and half females) in each group. PFASs included 13 perfluorocarboxylic acids (PFCAs) and 8 perfluorosulfonic acids (PFSAs), and the mixture was used as a test subject for intervention. The rats in the negative control group were given deionized water at doses of 20 mL/kg·bw, in the PFASs group were given 5 mL/kg·bw of PFASs mixtures and 15 mL/kg·bw of deionized water, and in the protein powder group were given 5 mL/kg·bw of PFASs mixtures and 15 mL/kg·bw of protein powder (0.258 g/mL). After intervention for 28 successive days, body weight and kidney mass were weighed, and the kidney volume index was calculated. Serum creatinine and blood urea nitrogen were detected by an automatic biochemical analyzer. The PFCAs, PFSAs and PFASs contents were quantified in blood and kidney using ultra-high performance liquid chromatography-electrospray tandem mass spectrometry, and the bioavailability was estimated. Results There was no significant differences in kidney mass, kidney volume index, serum creatinine and blood urea nitrogen among the negative control group, PFASs group and protein powder group (all P>0.05). The bioavailability of blood PFCAs, PFSAs and PFASs in the protein powder group was not significantly different from the PFASs group (all P>0.05). Compared with the PFASs group, the bioavailability of PFCAs, PFSAs and PFASs were significantly increased in kidneys of male rats in the protein powder group (all P<0.05), while were not significant different in those of female rats (all P>0.05). Conclusion Protein powder at the dose of this study can significantly improve the bioavailability of PFASs in kidneys of male rats, while there no obvious effects on the bioavailability of blood PFASs and renal function.
|
|
Received: 17 November 2023
Revised: 18 January 2024
Published: 20 March 2024
|
|
|
|
|
|
[1] ANDERSSON E M,SCOTT K,XU Y,et al.High exposure to perfluorinated compounds in drinking water and thyroid disease. A cohort study from Ronneby,Sweden[J]. Environ Res,2019,176:1-8.
[2] 侯沙沙,朱会卷,谢琳娜,等. 人体内全氟化合物的暴露水平研究进展[J]. 环境卫生学杂志,2020,10(2):218-225.
[3] 陈绩,李彤,吴限好,等. 全氟和多氟烷基化合物暴露特征与健康效应研究进展[J]. 环境与职业医学,2023,40(8):958-964.
[4] STANIFER J W,STAPLETON H M,TOMOKAZU S,et al.Perflfluorinated chemicals as emerging environmental threats to kidney health:a scoping review[J]. Clin J Am Soc Nephrol,2018,13(10):1479-1492.
[5] 刘小燕,屈艾,胡方方,等. 全氟辛烷磺酸钾对小鼠肾脏的氧化性损伤[J]. 现代生物医学进展,2017,17(20):3842-3845.
[6] 王广胤,孙伟强,马新壮,等. 芦丁对全氟辛酸所致的小鼠脂代谢紊乱及肾脏损伤的改善作用[J]. 广西医学,2022,44(17):1998-2002.
[7] JAIN R B,DUCATMAN A.Perflfluoroalkyl substances follow inverted U-shaped distributions across various stages of glomerular function:implications for future research[J]. Environ Res,2019,169:476-482.
[8] WANG J,ZENG X W,BLOOM M S,et al.Renal function and isomers of perflfluorooctanoate(PFOA)and perflfluorooctanesulfonate(PFOS):isomers of C8 Health Project in China[J]. Chemosphere,2019,218:1042-1049.
[9] DHINGRA R,LALLY C,DARROW L A,et al.Perflfluorooctanoic acid and chronic kidney disease:longitudinal analysis of a Mid-Ohio Valley community[J]. Environ Res,2016,145:85-92.
[10] 奚雨萌,闫俊书,应诗家,等. 高蛋白质高钙饲粮对雏鹅内脏型痛风发生、肾脏功能及肠道微生物区系的影响[J]. 动物营养学报,2019,31(2):612-621.
[11] 王杰明,王丽,冯玉静,等. 液相色谱-质谱联用分析动物内脏和肌肉组织中的全氟化合物[J]. 食品科学,2010,31(4):127-131.
[12] 蔡德雷,俞莎,郑熠斌,等. 大鼠肝21种全氟化合物生物利用率及蛋白粉作用研究[J]. 预防医学,2022,34(10):1069-1074.
[13] PIZZURRO D M,SEELEY M,KERPER L E,et al.Interspecies differences in perfluoroalkyl substances(PFAS)toxicokinetics and application to health-based criteria[J]. Regul Toxicol Pharmacol,2019,106:239-250.
[14] 朱永乐,汤家喜,李梦雪,等. 全氟化合物污染现状及与有机污染物联合毒性研究进展[J]. 生态毒理学报,2021,16(2):86-99.
[15] TURNER B D,SLOAN S W,CURRELL G R.Novel remediation of per- and polyfluoroalkyl substances(PFASs)from contaminated groundwater using Cannabis Sativa L.(hemp)protein powder[J]. Chemosphere,2019,229:22-31.
[16] LOUISSEL J,DELLAFORA L,VAN DEN HEUVEL J J M W,et al. Perfuoroalkyl substances(PFASs)are substrates of the renal human organic anion transporter 4(OAT4)[J]. Arch Toxico,2023,97:685-696.
[17] GAROVIC V D,AUGUST P.Sex differences and renal protection:keeping in touch with your feminine side[J]. J Am Soc Nephrol,2016,27(10):2921-2924. |
|
|
|
